GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » 3-Year EPS without NRI Growth Rate

Hangzhou AGS Medtech Co (SHSE:688581) 3-Year EPS without NRI Growth Rate : 57.50% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou AGS Medtech Co 3-Year EPS without NRI Growth Rate?

Hangzhou AGS Medtech Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.90.

During the past 12 months, Hangzhou AGS Medtech Co's average EPS without NRI Growth Rate was 27.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 57.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 7 years, the highest 3-Year average EPS without NRI Growth Rate of Hangzhou AGS Medtech Co was 57.50% per year. The lowest was 38.10% per year. And the median was 47.80% per year.


Competitive Comparison of Hangzhou AGS Medtech Co's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Hangzhou AGS Medtech Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou AGS Medtech Co's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou AGS Medtech Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Hangzhou AGS Medtech Co's 3-Year EPS without NRI Growth Rate falls into.



Hangzhou AGS Medtech Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Hangzhou AGS Medtech Co  (SHSE:688581) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Hangzhou AGS Medtech Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Hangzhou AGS Medtech Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou AGS Medtech Co (SHSE:688581) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kangxin Road, Building 597, Building 5, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311106
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.

Hangzhou AGS Medtech Co (SHSE:688581) Headlines

No Headlines